(Q71869479)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8958181%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Activity of gemcitabine in a human tumor cloning assay as a basis for clinical trials with gemcitabine. San Antonio Drug Development Team (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8958181%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

D D Von Hoff

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8958181%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8958181%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8958181%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8958181%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8958181%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

265-270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8958181%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00194529

21 October 2019

exact match

0 references

cites work

Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I study

1 reference

12 December 2020

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

1 reference

12 December 2020

The human tumor cloning assay in cancer research and therapy: a review with clinical correlations

1 reference

12 December 2020

Prospective clinical trial of a human tumor cloning system

1 reference

12 December 2020

Phase II study of gemcitabine in advanced colorectal adenocarcinoma

1 reference

12 December 2020

Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days

1 reference

12 December 2020

Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients

1 reference

12 December 2020

Gemcitabine in patients with advanced malignant melanoma or gastric cancer: phase II studies of the EORTC Early Clinical Trials Group

1 reference

12 December 2020

Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas

1 reference

12 December 2020

Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine

1 reference

12 December 2020

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

1 reference

12 December 2020

Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Clinical correlations with the human tumor cloning assay

1 reference

12 December 2020

A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

1 reference

12 December 2020

Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs

1 reference

12 December 2020

Activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human tumor colony forming units

1 reference

12 December 2020

Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).

1 reference

12 December 2020

Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia

1 reference

12 December 2020

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study

1 reference

12 December 2020

Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician

1 reference

12 December 2020

Primary Bioassay of Human Tumor Stem Cells

1 reference

12 December 2020

Phase II trial of gemcitabine in patients with advanced gastric cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00194529

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8958181%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference